Walsh S, Roelofs E, Kuess P, et al. Data from: A validated Tumor Control Probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy. 2015. doi:10.17195/candat.2015.10.8.

• DOI
• Google Scholar

Walsh - TCP meta-analysis of patients treated with photon, proton and c-ion radiotherapy (CSV) (15.82 KB) Walsh - TCP meta-analysis of patients treated with photon, proton and c-ion radiotherapy (XLS) (13.85 KB)

Eekers D, Roelofs E, Jelen U, et al. Data from: Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicenter in silico ROCOCO trial. 2016. doi:10.17195/candat.2016.04.2.

• DOI
• Google Scholar

Panth K, van den Beucken T, Biemans R, et al. Data from: MMP2 small immuno protein antibody uptake in xenograft tumors is associated with MMP2 activity. 2015. doi:10.17195/candat.2015.10.6.

• DOI
• Google Scholar

Panth_MMP2-activity-vs-uptake.csv (2.03 KB) Panth_MMP2-analysis.csv (6.1 KB) Panth_MMP2-representative-images.rar (570.44 KB)

Even A, Hamming-Vrieze O, van Elmpt W, et al. Data from: Quantitative assessment of Zirconium-89 labeled cetuximab using PETCT imaging in patients with advanced head and neck cancer - a theragnostic approach. 2016. doi:10.17195/candat.2016.11.1.

• DOI
• Google Scholar

Even_P0037C0006I4475579.ZIP (97.26 MB) Even_P0037C0006I5879176.ZIP (131.21 MB) Even_P0037C0006I6042760.ZIP (115.71 MB) Even_P0037C0006I8991415.ZIP (101.03 MB)

Roelofs E, Persoon L, Nijsten S, Wiessler W, Dekker A, Lambin P. Benefits of a clinical data warehouse with data mining tools to collect data for a radiotherapy trial. Radiotherapy and Oncology. 2013;108(1):174 - 179. doi:10.1016/j.radonc.2012.09.019.

• DOI
• Google Scholar

Loon J, Janssen MHM, Oellers MC, et al. PET imaging of hypoxia using [18F]HX4: a phase I trial. European Journal of Nuclear Medicine and Molecular Imaging. 2010;37(9):1663 - 1668. doi:10.1007/s00259-010-1437-x.

• DOI
• Google Scholar

Dubois LJ, Lieuwes NG, Janssen MHM, et al. Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging. Proceedings of the National Academy of Sciences. 2011;108(35):14620 - 14625. doi:10.1073/pnas.1102526108.

• DOI
• Google Scholar

Dubois LJ, Lieuwes NG, Janssen MHM, et al. Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging. Proceedings of the National Academy of Sciences. 2011;108(35):14620 - 14625. doi:10.1073/pnas.1102526108.

• DOI
• Google Scholar

Starmans MHW, Chu KC, Haider S, et al. The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer. Radiotherapy and Oncology. 2012;102(3):436 - 443. doi:10.1016/j.radonc.2012.02.002.

• DOI
• Google Scholar